SPECTRUM PHARMACEUTICALS INC - NOTE 2.750%12/1

CUSIP: 84763AAB4

Q2 2016 13F Holders as of 30 Jun 2016

Type / Class
Debt / NOTE 2.750%12/1
Market price (% of par)
92.31%
Total 13F principal
$109,689,731
Principal change
-$911,269
Total reported market value
$101,597,872
Number of holders
16
Value change
-$1,460,957
Number of buys
8
Number of sells
6

Quarterly Holders Quick Answers

What is CUSIP 84763AAB4?
CUSIP 84763AAB4 identifies 84763AAB4 - SPECTRUM PHARMACEUTICALS INC - NOTE 2.750%12/1 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of SPECTRUM PHARMACEUTICALS INC - NOTE 2.750%12/1 as of Q2 2016

As of 30 Jun 2016, SPECTRUM PHARMACEUTICALS INC - NOTE 2.750%12/1 was held by 16 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $109,689,731 in principal (par value) of the bond. The largest 10 bondholders included CITADEL ADVISORS LLC, HIGHBRIDGE CAPITAL MANAGEMENT LLC, WOLVERINE ASSET MANAGEMENT LLC, FMR LLC, SONORA INVESTMENT MANAGEMENT, LLC, OAKTREE CAPITAL MANAGEMENT LP, TENOR CAPITAL MANAGEMENT Co., L.P., LAZARD ASSET MANAGEMENT LLC, SSI INVESTMENT MANAGEMENT INC, and Context Capital Management, LLC. This page lists 16 institutional bondholders reporting positions for the Q2 2016 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.